Diverse Atty Group Proposed As Lead Counsel In Elmiron MDL

By Emily Field (January 14, 2021, 9:03 PM EST) -- Consumers alleging that Johnson & Johnson's pharmaceutical unit concealed a side effect of bladder cyst medicine that results in serious eye damage on Wednesday told a New Jersey federal judge that they have selected a diverse group of attorneys, a majority of whom are women, as the plaintiff steering committee.

The consumers said that the proposed leadership team follows U.S. Judge U.S. Judge Brian R. Martinotti's repeated directives for diversity and that of the 25 proposed members, 18 are women. That's important because most of the plaintiffs in the MDL are expected to be women, since interstitial cystitis, for which Elmiron is...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!